Guoqing Zhang Beibei Yan Yanan Guo Hang Yang Xiangnan Li Jindong Li
10.3389/fonc.2022.995624
Front Oncol
2022 Oct 31;12:995624.
egfr l718q afatinib cetuximab drug resistance lung adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/36387265/
Case Reports
PMC9659857
36387265
Case Report: A patient with the rare third-generation TKI-resistant mutation EGFR L718Q who responded to afatinib plus cetuximab combination therapy
2022